Join us every lunch from March 29 – 31 to see our handpicked posters that are demonstrating some of the most cutting edge research.
Our poster include:
POSTER 1 : New concept for generation of an effective and multi-level anti-HER-2 vaccine
Joshua Tobias1, Joanna Jasinska1, Karin Baier1, Christoph C. Zielinski2, Ursula Wiedermann1
1 Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Immunology & Infectiology, Medical University of Vienna, Vienna, Austria
2 Division of Oncology, Department of Medicine I, Medical University of Vienna, General Hospital, Vienna, Austria
POSTER 2 : Formulation of Ambient Temperature Stable Live Attenuated Measles and Rubella Vaccine Powders for Needle-Free Delivery Methods
V. Bronshtein., E.A. Miller, M. Collins, D. Uzri, M. Wang, P. Rota, A. Lackner, P. Aye, and M. Papania.
POSTER 3: Immunostimulatory Effects of Antigen-Conjugated InP/ZnS Quantum Dot Nanoparticles in an Avian Model
Chris S. Lyle1, Kristen A. Byrne1, Daniel M. Falcon1, Robert L. Dienglewicz1, Hyeonmin Jang1, Zoraida P. Aguilar2, and Gisela F. Erf1
Department of Poultry Science1, University of Arkansas, Fayetteville, AR, U.S.A; Zystein2, LLC, Springdale, AR, U.S.A.
POSTER 4: AAV Titer in Minutes: Nanoparticle Tracking Analysis (NTA) Characterization of Gold Labelled Adeno Associated Virus (AAV) and Other Small Viruses
Jonathan G. Mehtala, Ph.D*, Ragy Ragheb, Ph.D*, Duncan Griffiths*
Malvern Instruments, Westborough MA
POSTER 5: Mass Cytometry based profiling of host responses to A/California/2009 (H1N1) influenza infection in human volunteers
David McIlwain, Alison Han, Mel Affrime, Bonnie Bock, Matthew Memoli, Kenneth Kim, Garry Nolan
Department of Microbiology and Immunology, Stanford University School of Medicinez
POSTER 6: Development of an Aerosol Delivery System for Multiple SIimultaneous Exposures of Rabbits to Aerosolized Bacillus Anthracis
Winston Lin, Jerry Wang, Lindsay Drabek, Janelle Kish, Rene Nevarez, Robert Baker, Lou Holland, and Bruce Gingras
IIT Research Institute, Chicago, IL, 60616
POSTER 7: Characterization of an E. coli expressed CRM197 Conjugate Vaccine Carrier Protein
Natalia Oganesyan*, John Van Druff*, Frank Robb#, Morgane Ollivault-Shiflett*, Raphael Simon# and Andrew Lees*
*Fina Biosolutions LLC, Rockville, MD. #University of Maryland Baltimore, MD.
POSTER 8: Cryobag Frozen Differentiated HL-60 Cells Performance Compared To Fresh Cells In Opsonophagocytic Assays
Liana Haraga, Glorie-Grace Lazaro, Mark Cutler, Andrew McKeen, Shannon Harris, Elena Kalinina, Kathrin U. Jansen
Pfizer
POSTER 9: Novel Universal Flu Vaccine Approach
Andrej Egorov
HSC Development GmbH
POSTER 10: Seroprevalence of HAI antibody titers to A/California/7/2009(H1N1)
TBC
WCCT
POSTER 11: High Throughput use of Haemagglutination Inhibition Assay During Phase 3 Clinical Trials Using Large Virus Panels
Nicolas Noulin
hVIVO
POSTER 12: Development of ViruSpot Imaging Technology for High Throughput Measurement of RSV-Neutralising Antibodies During Vaccine Trials
Nicolas Noulin
hVIVO
POSTER 13:
CRISPR/Cas9-based optimization of plant glycosylation system for the production of vaccines
Puna M. Maharjan, Yu Jeong Jeong, Aiden Park, Euni Sim, Sunghwa Choe
School of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 08826, Korea
POSTER 14:
Effective Stabilization of a Live Viral Vaccine by Lyophilized and Liquid SPS® Formulations - Example of a PRRSV Vaccine in Animal Health
Thomas Kriehuber, Roland Derwand, Jens Altrichter
Leukocare Biotechnology
POSTER 15:
Bacteriophage Virus-Like Particles: A Novel Technology for Vaccine Development
Christen JM1 O’Rourke JP1, Bolli E2, Rolih V2, Conti L2, Lanzardo S2, Pericle F1 and Cavallo F2.
1) Agilvax, Inc. 5901 Indian School Rd NE. Albuquerque, NM 87110.
2) Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino. Via Nizza, 52 - 10126, Torino, Italy.
POSTER 16: Influenza A attenuated vector as a universal intranasal vaccine against influenza A and B viruses
Egorov Andrej, Artem Krohin, Boris Ferko, Julia Romanova, Marina Stukova, Anna-Polina Shurygina, Ekaterina Romanovskaja-Romanko, Vera Krivitskaya and Vladimir Nebolsin
HSC Development GmbH, Technopark 1C, A-3430 Tulln, Austria
Pharmenerprises Ltd, Moscow, Russia
Institute of Influenza, St. Petersburg, Russia
POSTER 17: Structure-Based Designs of a RSV F Vaccine by a hPIV2 Vector Platform
Masayuki Fukumura (Mie University, BioComo Inc.), Junpei Ohtsuka (Mie University, BioComo Inc.), Masato Tsurudome (Mie University), Moriya Tsuji
(Rockefeller University/ADARC), Tetsuya Nosaka (Mie University)
POSTER 18: Development of a Safe Ebola Virus vaccine targeting Zaire EBV GP and a Malaria Vaccine candidate by a hPIV2 Vector Platform
Masayuki Fukumura (Mie University, BioComo Inc.), Junpei Ohtsuka (Mie University, BioComo Inc.), Masato Tsurudome (Mie University), Moriya Tsuji
(Rockefeller University/ADARC), Tetsuya Nosaka (Mie University)
POSTER 19: Development of a hPIV2 Vector Platform for Cancer Immunotherapy
Masayuki Fukumura (Mie University, BioComo Inc.), Junpei Ohtsuka (Mie University, BioComo Inc.), Masato Tsurudome (Mie University), Moriya Tsuji
(Rockefeller University/ADARC), Tetsuya Nosaka (Mie University)
POSTER 20:
Innate Immune Agonists Provide Safe and Balanced Adjuvant Activity
P. Probst1, J.B. Grigg1, E. Hemann2, Y-M. Loo2, R.C. Ireton2, C. Olsen1, M. Gale Jr.2, S.P. Iadonato1, K.M. Bedard1
1Kineta, Inc., Seattle, WA, USA and 2University of Washington, Seattle, WA, USA
POSTER 21:
Applying a Radioprotective Mn2+ Peptide Complex (MDP) to the Preparation of Irradiated Vaccines
Authors: Elena K. Gaidamakova and Michael J. Daly
Uniformed Services University of the Health Sciences (“America’s Medical School”), Bethesda, MD, USA, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA